GENT — Gentian Diagnostics ASA Share News
0.000.00%
Last trade - 00:00- NOK579.70m
- NOK517.17m
- NOK176.50m
Brief: Gentian Diagnostics Q2 EBITDA At NOK 8.1 Mln
Brief: Gentian Diagnostics Q2 EBITDA Up At NOK 8.1 Million
Brief: Essange Reagents And Gentian Diagnostics Announce Collaboration Agreement
Brief: Gentian Diagnostics: Vatne Capital Reduces Indirect Ownership
Brief: Gentian Diagnostics Renews Long-Term Partnership With Bühlmann Laboratories
Brief: Gentian Diagnostics Q4 EBITDA NOK 10.5 Million
Brief: Gentian Diagnostics Enters Exclusive Agreement With Global Diagnostics Company
Brief: Gentian Diagnostics Says Prioritizes Refinement, Causing Minor Ruo Delay
Brief: Gentian Diagnostics Q3 Sales Up 28% Y/Y
Brief: Gentian Diagnostics Q3 EBITDA Up At NOK 8.4 Million
Brief: Gentian Diagnostics Q2 Sales Of NOK 43.6 Mln
Brief: Gentian Diagnostics Q1 EBITDA Rises To NOK 14.0 Million
Brief: Gentian Diagnostics Proposes Dividend Of NOK 0.40 Per Share
Brief: Gentian Diagnostics Sales Up At NOK 32.7 Mln
Brief: Gentian Diagnostics Announces Death Of Founder Dr. Erling Sundrehagen
Brief: Gentian Diagnostics Granted European Patent For NT-proBNP Reference Method
Brief: Gentian Diagnostics Q2 EBITDA At NOK 6.8 Mln
Brief: Matti Heinonen Is Appointed CEO Of Gentian Diagnostics
Brief: Gentian Q1 EBITDA Turns To Profit Of NOK 4.8 Mln